A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors
clinical study on the safety and efficacy of PD1 combined with dc-Nk in the treatment of solid tumors
Solid Tumor
DRUG: pd-1 and DC-NK cells
occurrence of treatment related adverse events, occurrence of treatment related adverse events that are possible, likely. Or definitely related to study treatment., 1 year
clinical study on the safety and efficacy of PD1 combined with dc-Nk in the treatment of solid tumors